TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: noninfectious wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Postprandial gene expression profiles of cell defense markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma markers of metabolic lipids and hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DNA damage/repair responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: organizational culture improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: organizational climate improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: work attitudes improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Expired tidal volume (TVe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: active range of motion (ROM) in the interphalangeal joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fluctuations of applied pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Interval to the first shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: MDASI scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Asking patients about smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rude mortality rates
Endpoint domain: Mortality/survival
Primary endpoint: Mean days of fever resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibiotic modification rates
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of full-time care state
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Costs per QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TOTPAR-8 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) of S-ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) of R-ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(t) of S-ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(t) of R-ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of shallow anterior chamber
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of iridocorneal touch
Endpoint domain: Adverse events/effects
Primary endpoint: Median morphine milligram equivalent (MME) prescribed at discharge
Endpoint domain: Adverse events/effects
Primary endpoint: unimpaired grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HBV infection in B-cell NHL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Disease onset in patients with B-cell NHL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full IQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of clinically significant disabilities
Endpoint domain: Adverse events/effects
Primary endpoint: memory strength and retrieval performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post week-4 mortality
Endpoint domain: Mortality/survival
Primary endpoint: Anatomical cure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PQoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maternal satisfaction with intrapartum analgesia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in CBE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastrointestinal side effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lipid profiles improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: composite of cardiovascular death, myocardial infarction, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Motor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite end-point of death or myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Passive permeability of fluorescein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unidirectional permeability of fluorescein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Diabetes Treatment Satisfaction Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Diabetes Therapy‐Related Quality of Life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cardiovascular composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 4-years KSS-F score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol overconsumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in diabetic retinopathy (DR) grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: absolute walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom scores assessed on a visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in pore size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vitiligo disease activity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of muscle cramps in the legs
Endpoint domain: Adverse events/effects
Primary endpoint: Fisher's ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Months employed
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Public assistance received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: EGJ-CI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum zonulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of postoperative septicemia
Endpoint domain: Adverse events/effects
Primary endpoint: 1-min Apgar score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Umbilical cord vein pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary cure rate
Endpoint domain: Mortality/survival
Primary endpoint: BMI prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Waist circumference prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ease of stool passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change in disease activity variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 18-month mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Mean difference in Ptco2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACLS knowledge and skill retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: necrotic core zone reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gallbladder contractility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBD and CHD diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoperation for inadequate tissue perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: BBS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macroalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: doubling of creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: need for dialysis
Endpoint domain: Adverse events/effects
Primary endpoint: new dementia diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: asthma score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy against culture-confirmed influenza illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy against acute otitis media associated with culture-confirmed influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate-specific antigen level in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum urinary flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: global psychological distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge about MSI and IHC tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: satisfaction with preparation to make a decision for testing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decisional self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reliability of clinical assessment of range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin colour (red)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 3-year graft survival
Endpoint domain: Mortality/survival
Primary endpoint: incidence of graft loss (excluding death)
Endpoint domain: Mortality/survival
Primary endpoint: acute allograft rejection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in the appearance of wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: effectiveness of TPA vs RME/TPA combination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: burden of treatment for the patient
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Proportions of pregnancies resulting in live birth, fetal loss, or spontaneous abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Congenital anomalies in neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Quality of preparation adequacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: History of sunburns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Melanocytic naevi count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: effective rate for skin pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: effective rate for anorexia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease of ALP and increase of albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Rate of subclinical atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of clinical atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achievement and maintenance of remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in thickness of herniation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postimmunization antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: quiet-sleep occurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrences of fussing or crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcer-healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bleeding after ESD
Endpoint domain: Adverse events/effects
Primary endpoint: ENO, PBE, and S‐ECP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relief of dyspareunia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relief of soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SES (Self-Efficacy Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ-5D (EuroQol-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average number of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory therapeutic response
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of satisfaction regarding adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Screw canal preparation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: General fitness rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in sedentary behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fear-avoidance beliefs reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC0-infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global improvement in severity and symptoms of BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid levels (total cholesterol, LDL-C, HDL-C, triglycerides)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dyslipidemia adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Limb fat changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage time CPAP within ± one cm H2O of set pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturations in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: finger-tapping speed in the paretic hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean serum creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: calculated creatinine clearances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time of muscle relaxation recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dosage of cisatracurium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cases of insufficient muscle relaxation
Endpoint domain: Adverse events/effects
Primary endpoint: gastric volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: hunger
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total gastric content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: overall cosmetic appearance of the eyelids
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean change in Bishop score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent delivered by 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's worst postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in K10 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ferguson angle correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voutsinas index correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech reception threshold improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Removal of K(+) in RBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: RBC recovery 1 day after transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean area under curve (AUC) at 1 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric pH 7 after 1 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transient rise in pH at 10-20 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Impression of Improvement (PGI-I)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Marginal gap measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal fit at the centro-occlusal site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time efficiency of digital impressions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Control of serum LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: post-CTS AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of postcesarean endometritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Levels of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stromal edema and collagen disorganization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal concentration of SA after administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time for SA after administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute bioavailability of the test formulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher BS in AS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased interruptions during QS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Responsiveness Scale (SRS) total score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Ottawa scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bloating
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of medications per patient with unexplained discrepancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of unexplained discrepancies per patient with potential for severe harm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of sensory blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of motor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to reach maximal dermatomal level of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean LLGR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis free status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement judged by treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: negative mood improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: spontaneous MN yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chromatid breaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dose-rate sparing index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival for FS+MTA pulpotomy and RCT incisors
Endpoint domain: Mortality/survival
Primary endpoint: clinical outcomes for FS+MTA pulpotomy and RCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes